skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Female remover assunto: Leukemia remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pulmonary sarcoidosis following stem cell transplantation: Is it more than a chance occurrence?
Pulmonary sarcoidosis following stem cell transplantation: Is it more than a chance occurrence?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pulmonary sarcoidosis following stem cell transplantation: Is it more than a chance occurrence?

BHAGAT, Rajesh ; RIZZIERI, David A ; VREDENBURGH, James J ; CHAO, Nelson J ; FOLZ, Rodney J

Chest, 2004-08, Vol.126 (2), p.642-644 [Periódico revisado por pares]

Northbrook, IL: American College of Chest Physicians

Texto completo disponível

Citações Citado por
2
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm

Pemmaraju, Naveen ; Lane, Andrew A ; Sweet, Kendra L ; Stein, Anthony S ; Vasu, Sumithira ; Blum, William ; Rizzieri, David A ; Wang, Eunice S ; Duvic, Madeleine ; Sloan, J. Mark ; Spence, Sharon ; Shemesh, Shay ; Brooks, Christopher L ; Balser, John ; Bergstein, Ivan ; Lancet, Jeffrey E ; Kantarjian, Hagop M ; Konopleva, Marina

The New England journal of medicine, 2019-04, Vol.380 (17), p.1628-1637 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia

Giles, F J ; Swords, R T ; Nagler, A ; Hochhaus, A ; Ottmann, O G ; Rizzieri, D A ; Talpaz, M ; Clark, J ; Watson, P ; Xiao, A ; Zhao, B ; Bergstrom, D ; Le Coutre, P D ; Freedman, S J ; Cortes, J E

Leukemia, 2013-01, Vol.27 (1), p.113-117 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Targeting of the MNK–eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function
Targeting of the MNK–eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting of the MNK–eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function

Lim, Sharon ; Saw, Tzuen Yih ; Zhang, Min ; Janes, Matthew R ; Nacro, Kassoum ; Hill, Jeffrey ; Lim, An Qi ; Chang, Chia-Tien ; Fruman, David A ; Rizzieri, David A ; Tan, Soo Yong ; Fan, Hung ; Chuah, Charles T H ; Ong, S Tiong

Proceedings of the National Academy of Sciences - PNAS, 2013-06, Vol.110 (25), p.E2298-E2307 [Periódico revisado por pares]

United States: National Acad Sciences

Texto completo disponível

Citações Citado por
5
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis

Michelis, Fotios V. ; Gupta, Vikas ; Zhang, Mei‐Jie ; Wang, Hai‐Lin ; Aljurf, Mahmoud ; Bacher, Ulrike ; Beitinjaneh, Amer ; Chen, Yi‐Bin ; DeFilipp, Zachariah ; Gale, Robert Peter ; Kebriaei, Partow ; Kharfan‐Dabaja, Mohamed ; Lazarus, Hillard M. ; Nishihori, Taiga ; Olsson, Richard F. ; Oran, Betul ; Rashidi, Armin ; Rizzieri, David A. ; Tallman, Martin S. ; de Lima, Marcos ; Khoury, H. Jean ; Sandmaier, Brenda M. ; Weisdorf, Daniel ; Saber, Wael

Cancer, 2017-06, Vol.123 (11), p.2035-2042 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
6
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR
Material Type:
Artigo 		Adicionar ao Meu Espaço

Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR

Wieduwilt, Matthew J ; Stock, Wendy ; Advani, Anjali ; Luger, Selina ; Larson, Richard A ; Tallman, Martin ; Appelbaum, Frederick ; Zhang, Mei-Jie ; Bo-Subait, Khalid ; Wang, Hai-Lin ; Bhatt, Vijaya Raj ; Dholaria, Bhagirathbhai ; Eapen, Mary ; Hamadani, Mehdi ; Jamy, Omer ; Prestidge, Tim ; Pulsipher, Michael ; Ritchie, David ; Rizzieri, David ; Sharma, Akshay ; Barba, Pere ; Sandmaier, Brenda M ; de Lima, Marcos ; Kebriaei, Partow ; Litzow, Mark ; Saber, Wael ; Weisdorf, Daniel

Leukemia, 2021-07, Vol.35 (7), p.2076-2085 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia

WEINBERG, J. B ; VOLKHEIMER, A. D ; RIZZIERI, D. A ; LEVESQUE, M. C ; DEKROON, R ; STRITTMATTER, W. J ; MIHOVILOVIC, M ; JIANG, N ; CHEN, Y ; BOND, K ; MOORE, J. O ; GOCKERMAN, J. P ; DIEHL, L. F ; DE CASTRO, C. M

Leukemia, 2008-12, Vol.22 (12), p.2184-2192 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy

Griffin, Patrick T. ; Komrokji, Rami S. ; De Castro, Carlos M. ; Rizzieri, David A. ; Melchert, Magda ; List, Alan F. ; Lancet, Jeffrey E.

American journal of hematology, 2015-09, Vol.90 (9), p.796-799 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
9
Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study
Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study

Cortes, Jorge, Prof ; Feldman, Eric, Prof ; Yee, Karen, MD ; Rizzieri, David, MD ; Advani, Anjali S, MD ; Charman, Anthony, PhD ; Spruyt, Richard, BSc ; Toal, Martin, FFPM ; Kantarjian, Hagop, Prof

The lancet oncology, 2013-04, Vol.14 (4), p.354-362 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia
Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia

Zimdahl, Bryan ; Ito, Takahiro ; Blevins, Allen ; Bajaj, Jeevisha ; Konuma, Takaaki ; Weeks, Joi ; Koechlein, Claire S ; Kwon, Hyog Young ; Arami, Omead ; Rizzieri, David ; Broome, H Elizabeth ; Chuah, Charles ; Oehler, Vivian G ; Sasik, Roman ; Hardiman, Gary ; Reya, Tannishtha

Nature genetics, 2014-03, Vol.46 (3), p.245-252 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (118)

Data de Publicação 

De até
Refinar
  1. Antes de2004  (7)
  2. 2004Até2008  (12)
  3. 2009Até2013  (31)
  4. 2014Até2019  (57)
  5. Após 2019  (16)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.